Biotech legend Termeer joins the board at Moderna

John Carroll

Cambridge, MA-based Moderna Therapeutics has scored another coup. The , which struck a major development deal with AstraZeneca ($ AZN) just months after it shed stealth status, has landed former Genzyme CEO Henri for the of directors. "It is an exciting time to be joining the of , which I believe has the potential to transform the way in which protein therapeutics are developed, and to address diseases that are not currently reachable by recombinant technologies," Termeer said in a statement. " shares the same vision, ambition, and potential as many of the early biotechnology leaders. I look forward to helping the company deliver on its vast potential to improve the lives of patients across a wide array of disease areas." Release


FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS